Zobrazeno 1 - 10
of 280
pro vyhledávání: '"Z, Mechl"'
Autor:
J. Hrbek, Petr Szturz, A. Vokáčová, Z Mechl, I Spička, P. Steyerová, M. Sýkora, J. Štork, M Zurek, Z Adam, Zdeňka Čermáková, Jiří Mayer, A Sedivá
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 27(2)
Background Schnitzler syndrome is a very rare, acquired, autoinflammatory disease of mostly adult onset with characteristic combination of chronic recurrent urticaria and monoclonal immunoglobulin M or G gammopathy predisposing the patients to malign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dc0dddcc6117bdd3cc2b7899539625a
https://pubmed.ncbi.nlm.nih.gov/24739048
https://pubmed.ncbi.nlm.nih.gov/24739048
Autor:
S. Eckhardt, M. Nekulova, Z. Mechl, I. Hindy, R. Tomek, J. Röthig, F. Gyergyay, K. Kolaric, Decker A, I. Sawinsky, S. Kerpel-Fronius
Publikováno v:
European Journal of Haematology. 38:67-69
SUMMARY Twenty-five breast cancer patients previously not exposed to adriamycin, were treated with 30 mg/m2/day aclarubicin for four consecutive days. Out of the 19 evaluable cases 1 CR and 2 PR were observed giving an overall remission rate of 16%.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c12967da8e618fddb05334f6f01eca73
https://doi.org/10.1111/j.1600-0609.1987.tb00026.x
https://doi.org/10.1111/j.1600-0609.1987.tb00026.x
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 26(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::88014c3827cc7dc4144e580a90e04c11
https://pubmed.ncbi.nlm.nih.gov/23961863
https://pubmed.ncbi.nlm.nih.gov/23961863
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 25(6)
The primary aim of palliative treatment is to improve the quality of life, followed by prolongation of overall survival. The effective regimens are usually complicated by increased side effects, particularly hematologic. Under these conditions, usefu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c98e92c6dbabac6ea55e6bfc24104278
https://pubmed.ncbi.nlm.nih.gov/23301650
https://pubmed.ncbi.nlm.nih.gov/23301650
Publikováno v:
Vnitrni lekarstvi. 57(3)
High-risk human papillomavirus (HPV) are implicated in the development of a subset of head and neck cancers, especially those arising from the lingual or palatine tonsils. HPV-associated cancer of the head and neck represent a different disease entit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::11110ee28485b774327ce25998a14ccb
https://pubmed.ncbi.nlm.nih.gov/21495410
https://pubmed.ncbi.nlm.nih.gov/21495410
Publikováno v:
Vnitrni lekarstvi. 57(3)
The number of malignant diseases increases and the question is why. Why is there an increasing incidence of certain cancers and why an increasing number of people dies from them? We do not have a clear answer to these questions. We just know that a d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::22b742e6e3de5aedd4f0ad1cd410828d
https://pubmed.ncbi.nlm.nih.gov/21495408
https://pubmed.ncbi.nlm.nih.gov/21495408
Autor:
E. Kánitz, G. Ringwald, M. Pawlicki, E. Kaplan, J. Rolski, S. Eckhardt, Krsto Kolarić, Jacek Jassem, D. Vukas, Z. Schoket, Z. Mechl
Publikováno v:
Oncology. 49:327-332
One hundred and eleven previously untreated patients with extensive small cell lung cancer were included in a prospective randomized study with the aim to assess the efficacy and tolerance of high-dose epirubicin (120 mg/m2) in combination with eithe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f41cab219b1e1c5b076db484759e0dc
https://doi.org/10.1159/000227066
https://doi.org/10.1159/000227066
Autor:
Z. Mechl, K. Kolarić
Publikováno v:
Oncology. 48:93-96
On the basis of results obtained with oral idarubicin administration in breast cancer, which have shown an established antitumor activity in approximately 28% of cases, this compound was combined with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::499de41aa7235f1a71d98ef66d63cfa3
https://doi.org/10.1159/000226903
https://doi.org/10.1159/000226903
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 21(2)
Head and neck squamous cell cancer (HNSCC) management is evolving rapidly. Approaches under exploration include induction chemotherapy, altered fractionation radiation with chemotherapy, intensity modulated radiation therapy (IMRT) and the use of bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d3fe428db933aff8a12a5afc811e6b5e
https://pubmed.ncbi.nlm.nih.gov/19102211
https://pubmed.ncbi.nlm.nih.gov/19102211
Autor:
A. Telekes, Bozena Sopkova, László Thurzó, Sándor Eckhardt, Z. Mechl, Marek Pawlicki, S. Kerpel-Fronius, Zoltán Hernádi
Publikováno v:
Oncology. 47:289-295
The objective of this trial was to define the antitumor activity and toxicity of etoposide for second-line treatment of patients with bulky ovarian carcinoma. Between February 1, 1986 and November 1, 1988 we recruited 82 patients. Out of them 77 (93.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71f9d3724687705bfe3c753f41219f44
https://doi.org/10.1159/000226835
https://doi.org/10.1159/000226835